The Viral Immunology Laboratory (VIL) aims to deeply understand immunological principles underlying responses to viral infections and vaccinations and ultimately develop preventive and therapeutic measures for immune-associated diseases including infectious diseases and cancers. In addition, studying molecular and cellular mechanisms of immuno-pathogenesis during respiratory viral infections such as influenza virus and SARS-CoV-2 (COVID-19 virus) are one of the current research topics. Especially, we are investigating how the innate immune system bolsters antibody and T cell responses, seeking to establish the bases for modulating the magnitude and longevity of immune protection. For a translational research axis, we are contributing to the development of advanced vaccine platforms including mRNA vaccines.
Our research interests can be summarized as follows:
• Immune responses and immunopathology triggered by influenza viruses and coronaviruses
• Investigation of efficacy and underlying mechanisms of vaccine and adjuvant
• Identification of novel immune-regulatory molecules using an innovative cell-based high throughput screening system
Members
Head
Eui Ho Kim, Ph.D.
Doctorate: University of Wisconsin-Madison (2014)
Post-Doctorate: Emory University (2014-2017) (PI: Bali Pulendran)
Research Fellow at NIEHS/NIH (2018)
CTO at NA Vaccine Institute (2019)
Head, Viral Immunology Lab, Institut Pasteur Korea (2020-Present)